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ABSTRACT
Introduction: leptospirosis is a zoonosis of worldwide importance. The disease is endemic in Brazil. 
This study was conducted to describe the clinical and laboratory presentation of leptospirosis in a 
metropolitan city of Brazil. Methods: this is a retrospective study including 201 consecutive patients 
with leptospirosis admitted to tertiary hospitals in Fortaleza, Brazil, between 1985 and 2006. All 
patients had clinical and epidemiological data suggestive of leptospirosis, and positive laboratorial 
test for leptospirosis (microscopic agglutination test, MAT, higher than 1:800). Results: a total of 201 
patients were included, with mean age of 38.9 ± 15.7 years; 79.1% were male. The mean length from 
onset of symptoms to admission was 7 ± 3 days. The main clinical signs and symptoms at admission 
were fever (96.5%), jaundice (94.5%), myalgia (92.5%), headache (74.6%), vomiting (71.6%) and 
dehydration (63.5%). Hemorrhagic manifestations were present in 35.8%. Acute kidney injury was 
found in 87% of the patients. Platelet count was less than 100,000/mm3 in 74.3%. Hematuria was 
found in 42.9%. Death occurred in 31 cases (15.4%). Conclusions: leptospirosis is a globally relevant 
disease with potential fatal outcome. Signs and symptoms suggestive of leptospirosis must be known 
by any physician in order to institute early adequate treatment to improve outcome. Early indication 
and daily hemodialysis seems to be beneficial in this group of patients.
Keywords: leptospirosis, clinical manifestations, laboratory findings, mortality.
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INTRODUCTION
Leptospirosis is a worldwide zoonotic disease 
caused by pathogenic leptospires belonging to 
the Leptospira spp. genus that affects predomi-
nantly men. The incidence of human infec-
tion is higher in the tropics than in temperate 
regions.1-3 Human infection results from ex-
posure to infected urine of carrier mammals, 
either directly or via contamination of soil or 
water. Leptospirosis is associated with occupa-
tional and recreational activities.4-6
Most infected subjects by Leptospira have 
asymptomatic infection or present mild symp-
toms, especially in endemic areas. Leptospirosis 
typically has two clinical forms: anicteric and 
icterohaemorrhagic. Fever, chills, headache, se-
vere myalgia, conjunctival suffusion, anorexia, 
nausea, vomiting, and malaise usually character-
izes acute leptospirosis.7-9
Pulmonary involvement and acute kidney in-
jury are the main causes of death in leptospirosis.10-
12 Renal involvement in leptospirosis is character-
ized by acute interstitial nephritis that may be 
associated with acute tubular necrosis. Predispo-
sition to hypokalemia is another particular fea-
ture of renal involvement in this disease.13
The present study describes the clinical and 
laboratory findings of patients with leptospiro-
sis admitted to tertiary hospitals in Brazil.
METHODS
A retrospective study was conducted with 201 
consecutive patients with confirmed diagnosis 
of leptospirosis admitted to the Walter Can-
tídio University Hospital and São José Infec-
tious Diseases Hospital, in Fortaleza city, a 
metropolitan area in Northeast Brazil, from 
May 1985 to December 2006. All patients had 
clinical and epidemiological data suggestive of 
leptospirosis, and 75% of them had positive 
test for leptospirosis (microscopic agglutina-
tion test, MAT, higher than 1:800).
Time between onset of symptoms and 
admission, length of hospital stay, treatment, 
need of dialysis and complications were ana-
lyzed. Severity of disease was analyzed through 
clinical and laboratory findings. Clinical investi-
gation included a record of all signs and symptoms 
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presented by each patient, as well as arterial systolic and diastolic 
blood pressure at hospital admission. Laboratory data included 
an assessment of serum urea, creatinine, potassium, bilirubin, 
transaminases, creatinokinase, lactate dehydrogenase, total blood 
count and prothrombin time.
Severity was considered if acute kidney injury and jaundice 
were present at admission. 
Hemorrhagic phenomena as gastrointestinal hemorrhage, 
hemoptysis and epistaxis were recorded at admission and dur-
ing hospitalization. Respiratory insufficiency was defined as 
need of mechanical ventilation. Acute kidney injury (AKI) was 
defined according to RIFLE criteria.14
Although controversial, antibiotic therapy was used in some 
patients. Penicillin G was administered at a dosage of 8 million 
units/day in the first 7 to 10 days after admission.
Dialysis was indicated in those patients that remained oliguric 
after effective hydration, in those cases where uremia was associ-
ated with hemorrhagic phenomena or severe respiratory failure. 
During the period of 1985 to 1996 the type of dialysis indicated 
was intermittent peritoneal dialysis (IPD) but in case of extreme 
hypercatabolic state, where the removal of urea was inadequately 
and in hemodynamically unstable patients, classic hemodialysis 
or continuous slow hemodialysis was indicated. During the pe-
riod of 1997 to 2006 only daily hemodialysis was performed.
The study protocol was reviewed and approved by the Ethi-
cal Committee of the Institutions.
Statistical analysis
The results were expressed through tables and summary meas-
ures (mean ± standard deviation) in the cases of quantitative 
variables. Statistical analysis was performed through the soft-
wares SPSS 10.0 (SPSS Inc. Chicago, IL, USA) and Epi Info, 
6.04b, 2001 (Centers for Disease Control and Prevention, USA). 
The Student’s t test, Fisher’s exact test and Wilcoxon test when 
appropriate. The descriptive values below 5% (p value < 0.05) 
were considered statistically significant.
RESULTS
A total of 201 patients were included, with a mean age 
of 38.9 ± 15.7 years old (range 8 to 84 years). There were 159 
(79.1%) males. The main occupations were farmer (12.6%), 
student (11.6%), housemaid (11.1%) and mason (10%). 
Twenty eighty percent had occupations considered at high risk 
for leptospirosis. The mean length between the onset of symp-
toms and hospital admission was 7.1 ± 3.2 days (range 1 to 28 
days). Almost 30% reported exposure to rats before the onset 
of symptoms and all the patients referred contact with stagnant 
water in the week prior to admission. The average period of 
hospital stay was 11.0 ± 7.1 days (range 0 to 42 days).
Seventy five percent of patients had serological tests 
higher than 1:800. Microagglutination test was positive 
for antibodies reactive with serovars Icteroaemorrhagiae in 
100%, Copenhageniin 59%, Cynopteri, Javanica, Djasiman 
and Pyrogenes in 9% each. 
Table 1. Clinical findings presented by patients with 
leptospirosis in Fortaleza, Brazil
   n = 201
Age (years) 38.9 ± 15.7
Gender
 Male, n (%) 159 (79.1%)
 Female, n (%) 42 (20.9%)
Onset of symptoms to admission (days) 7.1 ± 3.2
Length of hospital stay (days) 11.0 ± 7.1
History of contact with rats 29.8
Admission mean blood pressure  
 SBP (mmHg) 108.9 ± 20.7
 DBP (mmHg) 67.1 ± 14.8
Pulse (bpm) 101.6 ± 17
Signs and symptoms  
 Fever 96.5
 Jaundice 94.5
 Myalgia 92.5
 Headache 74.6
 Vomiting 71.6
 Dehydratation 63.1
 Chills 62.2
 Calf pain  51.7
 Diarrhea 42.3
 Hepatomegaly 37.8
 Anorhexia 37.3
 Oliguria 31.8
 Tachypneia 32.3
 Dyspnea 28.3
 Crackles or rhonchi 22.9
 Petechias 20.4
 Arthralgias 19.9
 Hemoptysis 13.4
 Hematemesis 12.9
 Conjunctival suffusion 11.9
 Edema 11.4
 Desorientation 9.4
 Flapping 5.4
 Constipation 4.9
 Splenomegaly 2.9
 Seizure 1.0
Dialysis (%) 50.7
Dialysis sessions (n) 3.2 ± 2.7
Death (%) 15.4 
 
Mean ± SD or %. SBP - systolic blood pressure, DBP - di-
astolic blood pressure.
The main signs and symptoms presented at admission were 
fever (96.5%), jaundice (94.5%), myalgia (92.5%), headache 
(74.6%), vomiting (71.6%), dehydratation (63.5%) and chills 
(62.2%), as summarized in Table 1. Oliguria was found in 31.8%. 
Hemorrhagic manifestations were present in 35.8%, including 
petechias (20.4%), hemoptysis (13.4%) and hematemesis (12.9%). 
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Acute kidney injury was found in 87% of the patients 
and 63.7% had serum potassium lower than 3.5mEq/L. 
Serum urea and creatinine had significantly increased dur-
ing the course of the disease (172.0 ± 90.6 vs. 193.2 ± 
91.2, p < 0.0001; 5.0 ± 2.9 vs. 5.5 ± 2.9, p < 0.0001, respec-
tively). There was significant decrease of serum potassium 
between the admission and minimal value during hospital 
stay (3.8 ± 1.2 vs. 3.3 ± 0.7, p = 0.0028).
Laboratory tests showed white blood count 14,370 
± 9,010/mm3 and platelet count 77,250 ± 67,920/mm3; 
69.8% had white blood count higher than 10,000/mm3 and 
74.3% had platelet count lower than 100,000/mm3. Direct 
and indirect bilirubin were 13.5 ± 9.8 and 5.6 ± 5.2 mg/
dL, respectively, and 85% presented direct bilirubin higher 
than 3.5 mg/dL. Aspartate amino transaminase (AST) was 
112.3 ± 106.4 IU/L and alanine amino transaminase (ALT) 
88.5 ± 110.7 IU/L. The AST and ALT levels were higher 
than 40IU/L in 82.4 and 72.1% of the patients, respectively. 
Creatine phosphokinase was 702.1 ± 2638 IU/L in admis-
sion and higher than 195 IU/L in 43.1%. Lactate dehydro-
genase was 693.7 ± 418.1 IU/L at admission and it had 
significantly increased during hospital stay (p = 0.0077). 
Urinalysis found hematuria in 42.9%. Laboratory findings 
are shown in Tables 2 and 3.
Table 2. Laboratory findings during hospital stay in patients with leptospirosis in Fortaleza, Brazil
laboratory findings Patients with data Mean ± SD or %  p
Hematocrit (%) 183 32.5 ± 6.0 
Hemoglobin (g/dL) 181 10.6 ± 1.9 
White blood count (x103/mm3) 159 14.37 ± 9.01 
Platelet count (x103/mm3) 156 77.25 ± 67.92 
Serum sodium (mEq/l)   
 Maximal 196 135.4 ± 11.7 
 Minimal 190 130.1 ± 11.1 < 0.0001(2)
Serum potassium (mEq/l)   
 Initial 189 3.8 ± 1.2 
 Minimal 193 3.3 ± 0.7 0.0028(1)
Serum urea (mg/dl)   
 Initial 159 172.0 ± 90.6 
 Maximal 166 193.2 ± 91.2 < 0.0001(1)
Serum creatinine (mg/dl)   
 Initial 192 5.0 ± 2.9 
 Maximal 201 5.5 ± 2.9 < 0.0001(1)
Serum calcium (mmol/L) 60 8.0 ± 1.9 
Serum phosphorus (mmol/L) 49 3.8 ± 1.0 
Serum clorum (mmol/L) 32 103.1 ± 11.7 
Prothrombin time (%) 58 59.3 ± 30.0 
AST (IU/L) 164 112.3 ± 106.4 
ALT (IU/L) 165 88.5 ± 110.7 
Direct bilirrubin (mg/dL) 160 13.5 ± 9.8 
Indirect bilirrubin (mg/dL) 162 5.6 ± 5.2 
lactate dehydrogenase (IU/l)   
 Initial 67 693.7 ± 418.1 
 Maximal 79 694.2 ± 422.9 0.0077(2)
Creatine phosphokinase (IU/l)   
 Initial 56 702.1 ± 2638.0 
 Maximal 58 625.6 ± 2593.8 0.1088(2)
Blood pH 102 7.37±0.06 
Blood HCO3 (mEq/L) 89 19.49±4.88 
Urinanalysis   
 pH 110 5.7 ± 0.7 
 Haematuria 175 42.9% 
MAT 106 75.5% 
% or Mean ± SD. (1) Student’s t-test, (2) Wilcoxon test. Initial, maximal and minimum value during hospital stay. AST - aspartate 
amino transaminase, ALT - alanine amino transaminase, HCO3 - bicarbonate, MAT - microscopic agglutination test (Cut-off > 1:800).
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laboratory findings Patients with data n (%) 
Haemoglobin < 12 g/dL 181 133 (73.4%)
White blood count > 10,000/mm3 159 111 (69.8%)
White blood count < 4,000/mm3 159 2 (1.2%)
Platelets < 100,000mm3 156 116 (74.3%)
Acute kidney injury 201 175 (87.0%)
K < 3.5 mEq/L 193 123 (63.7%)
Direct bilirrubin > 3.5 mg/dL 160 136 (85.0%)
AST > 40 IU/L 164 136 (82.4%)
ALT > 40 IU/L 165 119 (72.1%)
Prothrombin Time < 60% 58 20 (34.4%)
CPK > 195 IU/L 58 25 (43.1%)
K - potassium, AST - aspartate amino transaminase, ALT - alanine amino transaminase, CPK - creatine phosphokinase.
Table 4. Type of dialysis for patients with leptospirosis in the last 20 years – comparison of survivors and  
nonsurvivors
   Survivors Non-survivors p
   (n = 86) (n = 17) 
Peritoneal dialysis 49 (57.0%) 14 (82.4%) 0.04
Hemodialysis 37 (43.0%) 3 (17.6%) 0.04
Use of antibiotics 80 (93.0%) 13 (76.4%) 0.09
Fisher’s exact test
Figure 1: Leptospirosis patients without dialysis, with peritoneal dialysis and with hemodialysis in the last 20 years.
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Complications observed during hospital stay were pul-
monary bleeding (14%), gastrointestinal bleeding (13%), 
atrial fibrillation (11.4%), pulmonary infection (6.0%), 
meningitis (1.0%) and pancreatitis (0.5%).
Antibiotic therapy with Penicillin G was administered 
in 131 (65%) of the patients, 38 (44.7%) of them between 
1985 and 1996 and 93 (80.1%) between 1996 and 2006. Jarisch-
Herxheimer’s reaction was not seen in these patients.
Dialysis was required for 103 cases (51.2%). The mean 
number of dialysis sessions was 3.2 ± 2.7 sessions. Among 
the patients submitted to dialysis, intermittent peritoneal 
dialysis (IPD) was performed in 63 (61.2%) and daily he-
modialysis (DHD) in 40 (38.8%). IPD was the predomi-
nant method during the period from 1985 to 1996 and 
DHD during the period from 1997 to 2006 (Figure 1). 
The change in dialytic methods from IPD to DHD was as-
sociated with a decrease in mortality (p < 0.05). The use 
of antibiotics was not associated with lower mortality 
(p > 0.05). These data are shown in Table 4.
Death occurred in 31 cases (15.4%). The main cause 
of death was pulmonary hemorrhage. Mortality rate was 
higher in the first decade than in the second one, 22.3% 
vs. 10.3%, respectively (p = 0.02). Factors associated with 
death were oliguria (OR = 7.5, 95% CI = 1.6-47.4), crackles 
on lung auscultation (OR = 8.01, 95% CI = 1.6-40.1) and 
advanced age (OR = 1.07, 95% CI = 1.01-1.14).
DISCUSSION
Leptospirosis is the most widespread zoonosis in the world, 
particularly in warm and humid places as in tropical coun-
tries. Most of the cases occur in men.9,11,15,17 The disease is 
more common among young people, as confirmed in the 
present study.9,11,16,19 The cases described here represent the 
severe end of the spectrum of leptospirosis. The availability 
of laboratory diagnostic tests would probably reveal many 
more cases, most of them anicteric.
The transmission usually results from direct or indirect 
exposure to the urine of leptospiruric animals. Farming 
is classically an occupation at increased risk.5 Mansour-
Ghanaei et al.9 found it as the main (60%) occupation 
among infected patients. Leptospirosis is also related to rec-
reational activities.4,19 
It is important to identify the serovars associated with hu-
man infections by leptospires. Andrade et al.20 identified the 
serovars Icterohaemorrhagiae and Copenhageni in 71% and 
18% of patients, respectively. Jauréguiberry et al.,19 studying 34 
patients, identified the serovars Grippotyphosa (30%), Ictero-
haemorrhagiae (15%) and Copenhageni (12%). Ko et al.3 found 
Leptospira interrogans serovar Copenhageni in 87% of the cases 
with positive blood cultures of patients with severe leptospiro-
sis. In the present study, microagglutination test was positive in 
100% for Icterohaemorrhagiae and in 59% for Copenhageni. 
In the present study, the main clinical signs and 
symptoms presented by the initial evaluation were fever 
(96%), jaundice (94%), myalgia (92%), headache (74%) 
and vomiting (71%). These are the most common find-
ings reported in leptospirosis.1,7,8,9,17,19 
Hemorrhagic manifestations are characteristic of 
Weil disease, and are potentially fatal. Patients can de-
velop important hemodynamic abnormalities, second-
ary to hypovolemia, which is caused by dehydration and 
direct effects of Leptospira toxins that damages vascular 
endothelium and increases permeability.21 Hemorrhage 
has become recognized as the most important mani-
festation of human leptospirosis and is increasingly 
reported over the world. Bleeding in leptospirosis may 
be the result of a defect in the primary hemostasis or a 
imbalance in secondary hemostasis by depletion of co-
agulation proteins because of enhanced coagulation or 
by activated fribrinolysis.22 In a recent study, Chierakul 
et al. measured plasma concentrations of fibrinogen, D-
dimer, thrombin-antithrombin III complexes, and pro-
thrombin fragment 1.2 and evaluated the disseminated 
intravascular coagulation score. The median concentra-
tions of fibrinogen, D-dimer, thrombin-antithrombin 
III complexes, and prothrombin fragment 1.2 were sig-
nificantly elevated in leptospirosis. Patients with lep-
tospirosis had significantly longer prothrombin times, 
longer activated partial thromboplastin times, and low-
er platelet counts.23 In the present study, hemorrhagic 
manifestations were present in 36% of the patients and 
the main manifestations were petechias, hemoptysis and 
hematemesis.
Acute kidney injury in leptospirosis is reported in 40-
60% of severe cases24 and is usually non-oliguric15,16,25. 
Daher et al.15 found a significantly higher mortality in 
patients with oliguric leptospirosis than in non-oliguric 
forms. In the present study, oliguria was observed in 
one third of the patients. Leptospirosis is one of the few 
causes of AKI that may present with hypokalaemia. Seg-
uro et al.25 found hypokalemia in 45% of 56 patients. In 
the present study, acute kidney injury was found in 87% 
of the patients and 63.7% had serum potassium lower 
than 3.5mEq/L. Daher et al.16 showed that, after lept-
ospirosis AKI, renal function recovery is fast and com-
plete after six months, except for urinary concentration 
capacity.
Thrombocytopenia is found in 50% of patients with 
leptospirosis and it correlates with worse prognosis.26 Tanti-
tanawat & Tanjatham27 found that platelet count lower than 
100,000/mm3 was an independent risk factor for death in 
leptospirosis patients. Other reports showed low platelets at 
admission in almost 95%.16,28 In the present study, 74% of 
the patients had platelet count lower than 100,000/mm3.
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evated as compared with other liver enzymes.1,29 Tanti-
tanawat & Tanjatham27 found that total bilirubin higher 
than 2.5 mg/dL was independently associated with se-
verity. In the present study, direct and indirect bilirubin 
were 13 and 5 mg/dL, respectively, and 85% presented direct 
bilirubin higher than 3.5 mg/dL. 
Chang et al.29 found AST and ALT levels of 117.27 and 
70.63 IU/L respectively. Jauréguiberry et al.19 found AST and 
ALT levels higher than 40 IU⁄ L in 83 and 86%, respectively. 
In a study with 72 patients from Turkey with confirmed di-
agnosis of leptospirosis the mean AST and ALT levels were 
higher in nonsurvivors than in survivors. ALT levels were 
within normal limits in 22.2% of cases, between the upper 
limit of normal and 200 IU in 61.1%, 200-500 IU in 8.3%, 
500-1000 IU in 6.9% and over 1000 IU in 1.4%30. In the 
present study, mean transaminases levels were 2.5-3 times 
higher than the normal upper limit. The AST and ALT lev-
els were higher than 40 IU/L in 82 and 72% of the patients, 
respectively. Icteric patients with mild increases in transami-
nases should always raise the suspicion of leptospirosis.
Urinalysis is frequently abnormal in leptospirosis, with 
hematuria occurring during the early phase of the ill-
ness.31 Hematuria was reported in 58-70% of patients with 
leptospirosis.9,19 In the present study, hematuria was found 
in 43% of patients.
The true incidence of pulmonary involvement is unclear 
but may range from 20–70%.32 Pulmonary hemorrhage seems 
to be increasing among patients with leptospirosis, as suggest-
ed by a study performed in Salvador, Brazil.33 This study iden-
tified 47 (10%) patients with severe pulmonary hemorrhagic 
syndrome (SPHS) among 474 patients with leptospirosis. 
Among the 47 SPHS case-patients, 7 (15%) and 20 (42%) had 
pulmonary hemorrhage and respiratory insufficiency, respec-
tively, at the time of hospitalization. Pulmonary hemorrhage 
is reported in 40-86% of patients with leptospirosis.33,34 The 
syndrome of diffuse alveolar hemorrhage, which is potentially 
lethal, consists of hemoptysis, bilateral airspace opacification 
on chest radiograph, and a decreased hematocrit secondary 
to bleeding from pulmonary microvasculature into the alveo-
lar space.35 Cardiac involvement is common in any form of 
leptospirosis.2 Alterations in the electrocardiographic tracing 
could be observed in the first 24 hours of hospitalization in 
approximately 2/3 of the patients with leptospirosis.36 Men-
ingitis can be a significant feature of leptospirosis, mainly in 
anicteric form. In a retrospective study of 43 children present-
ing with leptospirosis 23% had meningitis.2 Pancreatitis is de-
scribed as an uncommon complication of leptospirosis, but 
there are a considerable number of reports in literature.37-40 In 
the present study, the complications found were pulmonary 
bleeding (14%), tract intestinal bleeding (13%), atrial fibrilla-
tion (11.4%), pulmonary infection (6.0%), meningitis (1.0%) 
and pancreatitis (0.5%).
In general, acute kidney injury in leptospirosis is hy-
percatabolic and requires frequent dialysis. In the present 
study, during the period of 1985 to 1996 the type of di-
alysis indicated was intermittent peritoneal dialysis (IPD) 
but in case of extreme hypercatabolism where the re-
moval of urea was inadequately performed by IPD clas-
sic hemodialysis or continuous slow hemodialysis in he-
modynamically unstable patients were indicated. During 
the period of 1997 to 2006 only daily hemodialysis was 
performed in our patients. Dialysis was required for 51% 
of the patients. The need of dialysis reported in literature 
ranges from 6% to 49%.19,41-43 In the present study, inter-
mittent peritoneal dialysis was performed in 61% and 
daily hemodialysis in 39% of the patients who underwent 
in dialytic therapy.
Andrade et al.20 compared the “delayed alternate-day” 
and the “prompt and daily dialysis” in patients with Weil’s 
disease. There was no difference in terms of the time to 
recovery of renal function, but the mortality was signifi-
cant lower in the “prompt and daily dialysis” group (17% 
vs. 67%, p = 0.01). In the present study, the type of di-
alysis during the period of 1985 to 1995 was intermittent 
peritoneal dialysis and the mortality was 22%. During the 
period of 1996 to 2006 the early indication and daily he-
modialysis was performed and the mortality decreased to 
10% (p < 0.02). 
The indications for antibiotic therapy in leptospirosis 
remain controversial. Administration of antibiotics seems to 
be effective when initiated up to the fourth day after onset 
of symptoms and several studies have suggested that the use 
of antibiotic therapy could be beneficial.44,45 Some reports, 
however, suggest that penicillin therapy did not provide bet-
ter clinical outcome in patients with leptospirosis and acute 
kidney injury, mainly after at least four days of symptomatic 
disease.12,46 In the present study, Penicillin G was adminis-
tered in 131 (65%) of the patients. The majority of these 
patients, in the last decade, promptly received penicillin as 
soon as they were admitted in the hospital. In this group of 
patients we observed a decreased mortality. 
The pulmonary complications to leptospirosis are the 
main cause of death in our country.10 Previous studies shows 
that the main cause of mortality was acute renal failure, and 
this has changed in the last years, with pulmonary hemor-
rhagic complications becoming the most important cause of 
death in leptospirosis.11,33 Death is also attributed to acute kid-
ney injury in a significant number of cases.11,12 Jauréguiberry 
et al.19 reported no deaths among 34 patients. Costa et al.11 
found 14.2% of death among severe leptospirosis cases. Costa 
et al.12 reported 9% of nonsurvivors among 253 patients. In 
the present study, death occurred in 15.4% of cases, and the 
majority of them were due to pulmonary bleeding. Factors as-
sociated with death among our patients were oliguria, crack-
les on lung auscultation and advanced age.
Clinical presentation of leptospirosis
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In summary, leptospirosis is a globally relevant disease 
with potential fatal outcome. Signs and symptoms sugges-
tive of leptospirosis must be known by any physician in 
order to institute early adequate treatment to improve out-
come. Early indication and daily hemodialysis seems to be 
beneficial in this group of patients.
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